Opportunity
DIBBS #SPE2DS-27-T-1402
DLA procurement of monoclonal anti-A blood grouping serum
Posted
November 04, 2026
Respond By
November 09, 2026
Identifier
SPE2DS-27-T-1402
NAICS
325414, 424210
DLA is seeking two packages of monoclonal anti-A blood grouping serum for medical use. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain; buyer contact listed as Seth Tootell. - OEMs / approved sources: Ortho Diagnostic Systems Inc. (P/N 711220) and CD Acquisition Holdings Inc. (P/N B5209A). The solicitation identifies both as approved sources. - Product: Two packages of 15, 10 mL each, of monoclonal anti-A blood grouping serum; NSN 6550-01-317-0288. Used to identify antigen A on red blood cells for ABO blood-group determination. - Requirements: FDA-regulated product; maintain refrigeration at 2–8°C. The serum has a 15-month, non-extendable shelf life, with at least 13 months remaining at delivery. - Delivery: FOB destination to the U.S. Army Medical Materiel Center Europe, required 84 days after award.
Description
BLOOD GROUPING SERUM, A (QTY: 2, NSN: 6550-01-317-0288, Purchase Request: 7018991828) Approved Sources: - CAGE: 61829, Part No: 711220 - CAGE: 64767, Part No: B5209A